Saint Luke's Hospital Mid America Brain and Stroke Institute
Kansas City, Missouri, United States
Medical clinic in Kansas City, Missouri
4401 Wornall Rd, Kansas City, MO 64111
About Saint Luke's Hospital Mid America Brain and Stroke Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
2
Neurobiological Technologies
1
Clinical Trials at Saint Luke's Hospital Mid America Brain and Stroke Institute
During the past decade, Saint Luke's Hospital Mid America Brain and Stroke Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
2006-03-01
2008-12-01
Terminated
311
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
2007-12-01
2012-06-01
Completed
1,331
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
2007-12-01
2012-04-01
Completed
1,121
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Luke's Hospital Mid America Brain and Stroke Institute"
#1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Saint Luke's Hospital Mid America Brain and Stroke Institute
According to Clinical.Site data, the most researched conditions in "Saint Luke's Hospital Mid America Brain and Stroke Institute" are
"Alzheimer's Disease" (2 trials), "Brain Infarction" (1 trials), "Cerebral Ischemia" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Saint Luke's Hospital Mid America Brain and Stroke Institute" in a lesser frequency.
Clinical Trials Intervention Types at Saint Luke's Hospital Mid America Brain and Stroke Institute
Most popular intervention types in "Saint Luke's Hospital Mid America Brain and Stroke Institute" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Placebo Control" (2 trials), "Ancrod (Viprinex)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Saint Luke's Hospital Mid America Brain and Stroke Institute
The vast majority of trials in "Saint Luke's Hospital Mid America Brain and Stroke Institute" are
3 trials for "All" genders.
Clinical Trials Status at Saint Luke's Hospital Mid America Brain and Stroke Institute
Currently, there are NaN active trials in "Saint Luke's Hospital Mid America Brain and Stroke Institute".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Saint Luke's Hospital Mid America Brain and Stroke Institute,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Saint Luke's Hospital Mid America Brain and Stroke Institute, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".